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Abstract: The urgent need to develop a detection system for Staphylococcus aureus, one of the most
common causes of infection, is prompting research towards novel approaches and devices, with a
particular focus on point-of-care analysis. Biosensors are promising systems to achieve this aim.
We coupled the selectivity and affinity of aptamers, short nucleic acids sequences able to recognize
specific epitopes on bacterial surface, immobilized at high density on a nanostructured zirconium
dioxide surface, with the rational design of specifically interacting fluorescent peptides to assemble
an easy-to-use detection device. We show that the displacement of fluorescent peptides upon the
competitive binding of S. aureus to immobilized aptamers can be detected and quantified through
fluorescence loss. This approach could be also applied to the detection of other bacterial species once
aptamers interacting with specific antigens will be identified, allowing the development of a platform
for easy detection of a pathogen without requiring access to a healthcare environment.
Keywords: Staphylococcus aureus; biosensors; molecular dynamics; circular dichroism; fluorescence;
nanostructured surface; point-of-care detection
1. Introduction
Staphylococcus aureus, a common commensal of skin and nares, is one of the most frequent causes of
infections [1,2], one of the five most common causes of infections after injury or surgery. Moreover, it has
become the second major bacterium in food poisoning since it is able to produce heat-resistant toxins [3].
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In addition, antibiotic-resistant strains of S. aureus (e.g., methicillin-resistant staphylococci) appeared not
only in clinical settings such as in hospitals, but also in whole communities [4]. These premises make
the development of rapid and reliable methods to identify S. aureus in biological samples as well as in
food an urgent need to avoid epidemics.
Pathogen detection mainly relies on microbiological and biochemical methods, but these are
usually time-consuming, expensive and not suitable for integration in on-site diagnosis. In fact,
conventional methods to detect S. aureus, such as cell cultures, require more than one day and cannot
distinguish among strains belonging to other species such as S. intermedius, S. caprae, S. simulans and
S. capitis [5]. Rapid S. aureus agglutination tests have been developed as an alternative for routine
diagnosis, but their accuracy, specificity and predictive capacity have been questioned [6–8]. Techniques
involving manual or automated biochemical methods exploiting colorimetric reactions are widely used
in clinical laboratories. They are faster than cell cultures and comparative studies indicate significantly
better results [9], but they require specific instrumentation and trained personnel. For these reasons,
there is currently a huge demand for alternative, rapid methods to detect S. aureus overcoming these
limitations [10,11]. The advent of real-time PCR led to the development of rapid methods (a few
hours), not requiring the bacteria isolation [12–14], but this technique requires expensive equipment
and trained personnel. Hence is not suitable for bedside point-of-care use. Moreover, PCR-based
methods are based on nucleic acids amplification, hence suffer from false positive results coming from
contaminants sequences amplification, as well as false negative results coming from template nucleic
acid degradation. As an alternative to nucleotides, peptide nucleic acids (PNAs), pseudopeptides
mimicking DNA, show improved binding behavior and higher stability, but their cost is still too high
for their application in this field. MALDI-TOF MS-based identification of bacteria is a fast and accurate
technology [15–18] and could be an alternative to molecular tests if the test accuracy is proven [19],
but requires an expensive instrument as well. Beside their interest and popularity, the costs, required
time and the need for trained personnel and fixed equipment make the applicability of these techniques
to point-of-care pathogen monitoring tools challenging to realize.
An attractive alternative is represented by biosensors, devices where a biological component, such
as a protein or oligonucleotide, is coupled with a transducer for obtaining a readable signal. Biosensors
may represent novel and user-friendly devices to handle human, animal of food samples, allowing the
rapid detection of bacteria without the need for expensive and fixed equipment.
The recognition of a bacterial pathogen such as S. aureus has been approached in different ways
by biosensors, exploiting proper transducers to give a readable signal (Table 1). Commonly reported
recognition tools are: (1) antibodies [20]; (2) bacteriophages [21]; (3) phage display peptides and
phage receptor binding proteins and (4) nucleic acids. While successful in immuno-analytic protocols,
antibodies are still costly, and show a relatively short shelf life and poor stability towards changes
in temperature, pH and ionic strength. Moreover, ethical issues regarding the need for animal
immunization for their production have to be considered. However, optical fibers-based biosensors
conjugated to monoclonal antibodies that bind methicillin-resistant Staphylococci have been recently
reported as a potential alternative to cell cultures [22]. Phages, which have better stability, and are
selective for single strains of bacteria, have still to be optimized in terms of immobilization density
and their purification remains challenging [23]. Nucleic acids are exploited for their capability to
complementary hybridize each other or to form more complex tridimensional structures able to
selectively recognize epitopes, similarly to antibodies.
As an example of the first case, an electrochemical DNA sensor based on DNA hybridization has
been recently developed and tested on contaminated food [24]. The second case is mainly represented by
aptamers, a novel and highly performing analytical tool for diagnostic applications [25]. Aptamers are
DNA or RNA segments acting as artificial recognition elements that are able to recognize conserved
epitopes on the surface of a bacterium. Aptamer libraries are continuously growing thanks to the recent
progress in the aptamer selection procedure (SELEX). Moreover, due to the relatively easy prediction of
their secondary structure, the possibility to modulate affinity towards a target by a rational modification
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of the sequence has been demonstrated [26]. While several aptamers are available for recognizing
S. aureus [27–33] and hence a set of molecular recognition probes is available, the development of a
proper transducer for a biosensor is still calling for an intensive research in the field of the technological
challenges in translating aptamer-based biosensors in clinical practice is the possibility to have substrate
materials adequate for the high density and functional immobilization of aptamers. A first endeavor
to overcome this limit relies in the use of carbon nanotubes (CNTs), chosen for their capability to
form hybrids with nucleic acids and transducing electrical signals with high efficiency, exploited
in the development of electrochemical sensors [10,34,35]. An ultra-sensitive method for bacterial
identification based on the resonance light-scattering signal of aptamer-conjugated gold nanoparticles
was used for detecting single S. aureus cells [36]. Other recent advances in the development of
aptamer-based S. aureus biosensors are based on gold electrode piezoelectric sensors [30] or silver
nanoparticles [31].
Despite these encouraging results, the development of surfaces able to immobilize aptamers
is still crucial and nanostructured surfaces are very promising for this kind of applications [37–42],
because they can allow high-density immobilization of biorecognition elements while retaining
their structure and functionality. In particular, it has been demonstrated that the surface nanoscale
morphology promotes protein [43–45] and aptamer [46] adsorption. Thus, producing nanostructured
substrates with well controlled and scalable roughness represents a unique asset for the implementation
of aptamers-based devices.
We took advantage of aptamers already known to interact with S. aureus to improve their surface
immobilization density, by adopting a nanostructured zirconium dioxide support to promote surface
linking. The final aim is to produce a detection system kit suitable for point-of-care use with a
user-friendly read-out. We proved the possibility of creating a detection kit by immobilizing on the
nanostructured support one of the highest affinity reported aptamers, SA23 [27]. The detection is based
on a fluorescein-labeled peptide bound to the aptamer that is displaced in the presence of bacteria and
released free in the solution, with a concomitant change of its fluorescence properties. Pathogens can
be detected by visual inspection, ideally simply by illuminating the device with a visible commercial
blue led.
The novelty of our biosensor development approach resides in coupling an already known
biorecognition element obtained with a high throughput approach (i.e., aptamers) with a rationally
designed element (specifically interacting peptides), to give an easily readable signal. To design
the structure of peptides we introduced in silico design in the development of a transducer [47,48],
i.e., a peptide able to selectively bind an aptamer based on its sequence.
The interacting peptide was designed in silico exploiting the energetic amino acid-base recognition
code previously obtained by estimating the interaction energy of several protein-DNA complexes with
the HINT force field [49]. The latter, originally developed for evaluating protein-ligand interactions [50],
has also been successfully applied to protein-protein [51], protein-water [52] and protein-DNA [49,53]
systems. Differently from complementary double stranded DNA, aptamers do not have a well-defined
three-dimensional structure and present a high level of flexibility [54]. It is known that aptamers are
predominantly unstructured molecules in solution, and fold upon association with the corresponding
ligands into molecular architectures, in which the ligand becomes an intrinsic part of the nucleic acid
structure [55]. This property was favorably exploited to increase the energy of interaction of peptides
specifically designed to bind aptamers. Starting from the aptamer sequence, the aforementioned
recognition code was used to predict the residues able to give stronger interactions, considering that
contacts as Arg and Lys with G, Asp and Glu with C, and Asn and Gln with A have demonstrated to be
conserved and to better stabilize protein-nucleic acid complexes [49]. The designed peptides were then
synthesized using stepwise solid phase synthesis (SPPS), exploiting the effectiveness of microwave
irradiation, which previously demonstrated its potential allowing the synthesis of a 75mer peptide [56].
We finally created a device where the fluorescein-labeled peptide, hybridized to the aptamer
immobilized on the nanostructured surface, is displaced by S. aureus and released in the biological fluid,
Sensors 2020, 20, 4977 4 of 23
losing its fluorescence. The properties of nanostructured materials could also fit in microfluidic devices,
that demonstrated to be useful in the concentration of pathogens, hence improving the detection
limit [57].
This approach can in principle be expanded towards any biological agent for which
selective aptamers have been identified. As a perspective, this platform has the potential for the
development of point-of-care detection avoiding to access the healthcare environment. The recent
SARS-CoV-2 pandemic highlighted how this aspect would be critical in the management of such
emergency conditions.
Table 1. Relevant S. aureus biosensors with their component properties and detection limit.
Biorecognition Element Detection Method DetectionLimit Ref.
PEI-GA modified antibody amperometric 10 CFU/mL [20]
lytic phage surface plasmon resonance-based sensor 104 CFU/mL [21]
monoclonal antibody optical fiber 104 CFU/mL [22]
hybridizing S. aureus DNA electrochemical (multiwalled carbonnanotubes-chitosan-bismuth) 3.17 × 10−14 M [24]
hybridizing S. aureus ssDNA chitosan–Co3O4 nanorod–graphene 4.3 × 10−13 M [58]
DNA aptamer potentiometric (single-walled carbon nanotubes) 8 × 102 CFU/mL [10]
DNA aptamer graphene interdigitated gold electrode 41 CFU/mL [30]
biotynilated DNA aptamers electrochemical (silver nanoparticles) 1.0 CFU/mL [31]
DNA aptamer fluorescence (labeled aptamer) 102 CFU/mL [32]
aptamer-conjugated gold
nanoparticles resonance light-scattering–detection system single cells [36]
2. Materials and Methods
2.1. In Silico Design
Two main criteria were followed during the aptamer design phases: (i) evaluation of the
aminoacid-nucleotide pairing suitability according to the employed pseudo-code [49]; (ii) the selection,
whenever possible, of residues bearing side chain with similar length with respect to the wild type ones.
2.2. Molecular Dynamics
The three-dimensional structure of SA23-2AII DNA single strand was generated using
MC-Fold-MC-Sym pipeline [59]. Then, the protein-aptamer complex was obtained by manually
placing the ssDNA molecules close to the CRO protein, according to the protein-DNA complex
reported in PDB 6cro [60]. We reproduced the interactions hypothesized by the mentioned recognition
code [49], residues 26–27 and 31–32 of CRO protein, which should interact with nucleobases at
position 2–3 and 16–20 of SA23 DNA sequence. To optimize the molecules and the relative interaction,
we submitted the SA23-2AII complex model to 500 ns of MD simulation using the GROMACS
5.0.5 package [61]. The complex was solvated in an octahedron box using the TIP3P water model,
maintaining a 1.1 nm distance from the molecule border [62]. Counter-ions were added to neutralize
the whole system. Temperature and pressure were controlled with the Berendsen algorithm [63],
following previous protocols [64–67]. The Ewald method was applied to model electrostatic interactions.
Before starting the equilibration, waters were minimized for 10 ps at 300 K, restraining protein and
RNA atomic positions with a harmonic potential. Starting from 50 K, the system was heated up
gradually to 300 K in six steps phases and the production run in NPT standard conditions for 500 ns,
without restraints. The MD trajectory was analyzed with GROMACS, VMD [61,68] and Pymol [69]
packages. The second part of the simulation was clustered to extract a representative conformation,
with the gromos clustering method [70]. The structure having the lowest RMSD, with respect to the
other cluster members, was considered as the most representative, for each cluster.
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2.3. Peptide Synthesis and Labeling
Peptide synthesis was carried out on a microwave-assisted solid phase-based peptide synthesizer,
followed by labeling with 5(6)-carboxyfluorescein [56,71].
2.4. Circular Dichroism
Circular dichroism (CD) spectra were recorded with a Jasco J-715 spectropolarimeter
(Jasco International Co. Ltd., Tokyo, Japan) thermostatted with a Peltier unit set at 20 ◦C. Secondary
structure estimation was performed by using the Dichroweb server [72,73].
2.5. Fluorescence Analysis
Fluorescence spectra of each peptide-aptamer complex were recorded on a Jasco FP-777
spectrofluorometer. The excitation wavelength was 488 nm and the emission wavelengths were
in the range from 510 to 610 nm. Peptides tagged with carboxyfluorescein were dissolved in 20 µM
phosphate buffer and titrated with different amounts of aptamer. The peptide-aptamer mixture
was incubated at room temperature for 15 min to allow the formation of the complexes before the
registration of each fluorescence spectrum.
2.6. Nanostructured Zirconia Substrates
Nanostructured zirconia (ns-ZrOx) thin films were grown on glass microscope slides by depositing
supersonic beam seeded with zirconia clusters produced by a pulsed microplasma cluster source
(PMCS) under high vacuum conditions [74–76]. A zirconium rod is ablated by a pulsed argon plasma
stream, ignited by an electric discharge. The removed materials thermalize in the quenching inert
gas and condense to form clusters. The mix of cluster and inert gas is extracted through a nozzle,
forming the seeded supersonic beam. The zirconia clusters are collected on substrates mounted on the
manipulator perpendicularly to the beam trajectory. Since the kinetic energy of the zirconia clusters
is sufficiently low to avoid fragmentation a cluster assembled film is grown. The films are partially
oxidized in the deposition apparatus due to the presence of oxygen traces; further oxidation occurs
upon exposure to air.
The surface roughness of the substrates is crucial for the molecules immobilization since it affects
their adsorption density and functionality [44,77,78]. Thus, the films were grown with deposition
parameters optimized for producing films with morphological properties suitable for the aptamers
immobilization. The rms roughness was estimated by AFM measurements, as extensively described
elsewhere [75]. The value chosen as optimal was 15 nm.
2.7. Aptamers Microarrays
The validation and quantification of the aptamers immobilization on ns-ZrO2 have been achieved
by using the protocol called protein surface interaction microarray (PSIM), which allows the high
throughput study of biomolecules-surfaces interactions [43]. The protocol applied takes advantage of
the biotin-streptavidin pairing to enhance the adsorption of aptamers on ns-ZrO2. Initially, a small
volume droplet (450 pL) of Streptavidin is spotted on slides with the zirconia nanostructured surfaces,
on top of those subsequent 450 pL droplets biotin-triethylene glycol (TEG) fluorescent aptamers
are spotted. All the spotting process has been performed using an automated sciFLEXARRAYER
S3-Scienion AG spotter (Scienion AG, Berlin, Germany). After incubation for 20 min at 65% controlled
humidity, the slides were blocked in a solution with PBSMT (PBS + 5 mM MgCl2 + 0.1% (v/v) Tween
20) for 10 min and washed 3 times in PBSMT for 3 min, 3 times in PBSM (PBS + 5 mM MgCl2) for
3 min and finally in doubly-distilled H2O for 1 min. Slides were then dried under gentle nitrogen
flux. The amount of adsorbed biomolecules is evaluated by reading the fluorescent signal with a
TECAN microarray scanner (Tecan Group Ltd., Männedorf, Switzerland), and images are analyzed
using Scan-array Express software (PerkinElmer Inc., Waltham, MA, USA). Figure S1 shows a sketch of
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PSIM protocol applied to 4 different fluorescent aptamers spotted on ns-ZrO2 substrate. SA23 has been
purchased from Sigma-Aldrich (Sigma-Aldrich Corp., St. Louis, MO, USA), aptamer SA23 biotin-TEG
5′ modified has been purchased from PrimmBiotech (PrimmBiotech, Inc., Cambridge, MA, USA).
The IIA2 fluorescent peptide is incubated in the aptamers microarray immediately after the blocking
step. The concentration of the peptide is 20 µM in PBS and incubation time is of 15 min.
2.8. Fluorescence Confocal Microscopy
The microscope slides have been imaged in the xy and xz planes using a Leica TCS SP5 confocal
microscope (Leica Microsystems, Wetzlar, Germany), using a diode (561 nm) laser with 30% laser
power, a 40× oil immersion objective, 1024 × 1024 image resolution and UV (405 nm) at 35% laser
power, 40× oil immersion objective and 1024 × 1024 image resolution (Figure S1).
2.9. Bacterial Culture
Staphylococcus aureus subsp. aureus (ATCC-25923) and Escherichia coli (ATCC-25922) are from
LGC Standards (LGC Standards s.r.l., Milan, Italy). The bacteria are cultured in solution, using LB
Broth (Miller) from Sigma-Aldrich as growth medium, in a thermoshaker at 37 ◦C overnight. Then
the concentration of bacteria is measured using a spectrophotometer at fixed wavelength (600 nm).
Before the incubation with the immobilized aptamers, the bacteria were stained with Hoechst 33,258
from Sigma-Aldrich (3 µL per mL of solution).
2.10. Detection of Bacteria-Aptamer Interaction
In order to detect the activity of aptamers immobilized on nanostructured surfaces for bacterial
recognition the following protocol has been established: incubation with 5 µM streptavidin for 20 min;
washing with PBSM 1 time for 5 min; incubation with 5 µM biotin-TEG-aptamer-Cy3 labelled for
15 min; washing with PBSMT 3 times for 3 min; incubation with S. aureus or E. coli, 108 bacteria/mL for
45 min at RT; washing with PBSMT and PBSM, 3 times for 3 min each.
2.11. Bacterial Displacement
The bacterial displacement experiments are based on the previously described procedures: round
cover glass (Ø 13 mm) coated with ns-ZrO2 (rms roughness 15 nm), coverage of the surface with
streptavidin (6.63 µM, 100 µL), incubation at RT for 20 min in 65% controlled humidity, washing in
PBSM, removal of PBSM, spotting of aptamer SA23 biotin-TEG modified (26.53 µM, 100 µL), incubation
at RT for 20 min in 65% controlled humidity, washing in PBSM, removal of PBSM, spotting of peptide
(50 µM, 100 µL), incubation at RT for 15 min in 65% controlled humidity (kept dark), plate reading
(TECAN), washing in PBSM, bacteria plating incubation with S. aureus or E. coli, 108 bacteria/mL for
45 min at RT (kept dark), washing with PBS, plate reading (Tecan) of the fluorescein signal (excitation
wavelength 485 nm, emission wavelength 535 nm).
3. Results and Discussion
3.1. Aptamer Selection for In Silico Design of Interacting Peptide
The five aptamers presented by Cao and coworkers [27] were considered for selecting the candidate
that could be better targeted by peptides designed in silico. SA23 (Figure 1a) was chosen among these
aptamers firstly for a structural peculiarity. According to the predicted secondary structure, in fact,
it presents a relatively long trait in double strand configuration (the hairpin made by nucleotides
16–44), with high GC content in the inner portion. This double strand DNA region of the aptamer was
then identified as the putative binding region of the peptides. Moreover, the SA23 aptamer results as
the one with the higher affinity towards S. aureus within this group.
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Figure 1. Aptamer folding prediction obtained with RNAstructure (https://rna.urmc.rochester.edu/
RNAstructureWeb/) for (a). Full lenght SA23; (b). SA23 short1 sequence; (c). SA23 short 2. Here the
predicted contacts with the mutated residues are also indicated. The color-code shows the level of
prediction reliability, as indicated in the legend.
3.2. Peptide Scaffold Selection
Once the proper aptamer was chosen, we identified among proteins able to interact with nucleic
acids λ-Cro as a suitable scaffold for the design of aptamer-interacting peptides [79]. λ-Cro is a 66 aa
protein that plays a pivotal role in the switch from lysogenic to lytic phase in the growth cycle of
phage λ and represented a suitable scaffold for several reasons: (i) the availability of three-dimensional
structures both in the presence and absence of its cognate DNA (PDB ID: 6cro [60] and 5cro [80],
respectively) allows detailed structural evaluations; (ii) the helix-turn-helix motif of the DNA binding
domain is relatively small and all the interactions between the nucleobases of the consensus sequence
and the peptidic backbone are well characterized; (iii) the minimum functional portion of the consensus
sequence is quite short and made by contiguous nucleobases along the two strands of the DNA
target; (iv) previous works reported successful examples of Cro reprogramming for binding consensus
sequences that differ from the wild type [79]. Moreover, the helix-turn-helix peptide domain of the
Cro protein showed to well mimic full-length protein for binding [79]. Therefore, the sequence of the
helix-turn-helix motif of Cro was mutated, accordingly to the previously reported recognition code,
to specifically bind SA23 double strand region.
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3.3. In Silico Design and Synthesis of λ-Cro Mutant Specific for Aptamer Binding
The selected portion of λ-Cro sequence suitable for in silico evaluation and following mutation
spans the residues 15–38 (wild type sequence: GQTKTAKDLGVYQSAINKAIHAG), that includes
almost the totality of the a-specific and pseudo-specific residues that interact with its cognate DNA
sequence, according to the complex reported by Olhendorf et al. (PDB ID: 6cro) [60]. The design
was performed using the complex as template and considering the peptides acting as a monomer,
which was reported to bind its operator site, with a binding constant of around 25 µM or above for the
wild type. This binding constant is theoretically appropriate for a system where the labeled peptide has
to be displaced by the aptamer that, on the contrary, shows binding constant in the nanomolar range.
The secondary structure of SA23 was predicted by using RNAstructure and is reported in Figure 1a.
As mentioned, the paired region was chosen as possible target. The interacting peptides have been
designed substituting the original residues to possibly generate more stable interactions with the
paired aptamer (Table 2).
Table 2. λ-Cro mutant peptides sequence.
Peptide Sequence MW (Da)
IA Ac-GQTKTAKDLGVYKSAIEEAIHAG 2428.73
IAser Ac-GQTKTAKDLGVYKDAIEEAIHAG 2456.73
IB2A Ac-GQTKTAKDLGVYDSAIEEAIHAG 2415.63
IIA Ac-GQTKTAKDLGVYESAIEEAIHAG 2429.67
IIA2 Ac-GQTKTAKDLGVYEDAIEKAIHAG 2456.74
IIA3 Ac-GQTKTAKDLGVYEDAIEFAIHAG 2475.74
IIA2M Carboxyfluorescein-GQTKTAKDLGVYEDAIEKAIHAG 2773
IA3M Carboxyfluorescein- GQTKTAKDLGVYEDAIEFAIHAG 2792
The peptides were synthesized using microwave assisted Fmoc-based solid phase peptide synthesis
on Rinkamide resin [56]. Labelled peptides were prepared on resin using 5,6 carboxyfluorescein as the
fluorescent tag [81].
3.4. λ-Cro Peptide Mutants Characterization by Far-UV Circular Dichroism
Circular dichroism experiments were carried out on λ-Cro peptide mutants optimized to interact
with the double strand portion of SA23 aptamer in 20 mM phosphate buffer, pH 7.4. Circular dichroism
was used to characterize the secondary structure of synthesized peptides, and hence to determine the
mutation effect on the structure stability. It has already been demonstrated that it is possible to mimic
the DNA binding behavior of λ-Cro by shorter, chemically synthesized peptides, representing the
helix-turn-helix region of the protein [79]. These peptides, also in dimeric form, showed significant
helical content only when α-amino isobutyric acid is introduced in the sequence [79]. To quantify
the λ-Cro mutant helical content, the spectra of the peptides were analyzed using Dichroweb server
(CDSSTR algorithm-reference set 7), yielding a low percentage of helical content (Table 3), highlighting
that the isolated peptides in solution are unstructured in the absence of the target nucleotide sequences.
Table 3. Peptides secondary structure estimated by Dichroweb server.
Peptide Helices Strand Turns Disordered
IA 17% 28% 18% 36%
IAser 21% 24% 20% 35%
IB2 21% 26% 21% 32%
IIA 19% 24% 20% 37%
IIA2 7% 32% 23% 37%
IIA3 5% 36% 17% 40%
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To verify that increasing the concentration the peptides does not result in the formation of
aggregates or oligomeric forms, CD spectra were collected as a function of peptide concentration
(10–100 µM). The CD spectra in this range of concentration appeared identical (data not shown).
Peptide solutions demonstrated to be stable even after 1–2 freeze-thawing cycles.
The use of circular dichroism for evaluating the interaction between SA23 aptamer and the
peptides requires also to characterize SA23 CD spectra. Since peptides were specifically designed to
bind a specific region on the aptamer (the hairpin formed by nucleotides 16–44), shorter sequences
were also characterized: SA23 short1 and SA23 short2, the former being the short paired sequence on
which the peptide is expected to bind, while the latter is the complete hairpin. CD spectra of SA23,
SA23 short1 (Figure 1b) and SA23 short2 (Figure 1c) were collected in the far-UV and near-UV regions.
3.5. Circular Dichroism Studies on Peptide-Aptamer Interaction
The peptide-aptamer interaction was first studied by near-UV CD spectroscopy. In this region,
only aptamers and not peptides contribute to the spectra. The analysis of this spectral region allowed
to monitor the peptide effect on the aptamer structure, without any interference from the peptide
conformational change.
Solutions containing aptamers and peptides at the same concentration (20 µM) were incubated
before recording the spectra. A comparison between the spectra of the aptamer-peptide mixture and
the arithmetic sum of the two separated components would highlight potential interactions.
The comparison between arithmetic and experimental mixtures highlighted no differences with
the short versions of SA23, SA23 short1 and SA23 short2, while a marked difference was observed for
the full length aptamer SA23 with the four peptides IIA2, IAser, IIA and IB2. In Figure 2 the comparison
between arithmetic and experimental mixtures for the IIA2 peptide is shown. The absence of CD
spectra difference between the mixtures and the arithmetic sums observed for the shorter versions of
SA23 (SA23 short1 and SA23 short2) may derive from the lack of conformational adjustment upon
peptide binding.
However, the collected data showed that the aptamer SA23 interacts with four peptides, promoting
a conformational change detectable by a CD band intensity decrease. The most evident effect was
observed for peptide IIA2, as reported in Figure 3 where the ellipticity at 280 nm is reported.
To demonstrate that peptide binding is determined by the specific mutation inserted on λ-Cro
peptide mutants, we synthesized and checked sequence-scrambled peptides, and peptides where
mutations causing unfavorable interaction were inserted. The comparison of the mixture of these
peptides with SA23 with the arithmetic sum gave overlapping results, demonstrating the absence of
interaction (data not shown).
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3.6. Fluorescence Characterization of Peptide-Aptamer Interactions
Based on CD results, further analyses were carried out by fluorescence spectrosco y, using the
ost promising IIA2 peptide labeled with fluorescein, in order to: (i) confirm peptide-aptamer
complex formation also after peptide labeling, and (ii) calculate the dissociation constants (Kd) of the
peptide-aptamer complex, which determination is prevented in circular dichroism measurements by
experimental limits of acquiring CD spectra at low concentrations.
The label d peptide was titrated with increasing concentrations of aptamers and spectral
perturbations were followed at 520 nm emission wavelength, allowing to calculate the dissociation
constants (Figure 4). In accordance with the CD measurements, specific binding could be detected
for the aptamer SA23 with peptide IIA2, with a measured Kd of 1.64 ± 0.20 µM. Differently form CD
measurements, fluorescence analysis was able to detect peptide binding also to the shorter versions of
SA23, SA23 short 1 and SA23 short 2, for which a Kd of 5.81 ± 0.21 and 9.61 ± 0.77 µM was obtained,
respectively. These data demonstrated that IIA2 peptide is able to bind to SA23 with an affinity in a
low micromolar range, and peptide binding is specific for the target sequence, as demonstrated by
binding of SA23 short 1 and SA23 short 2, that showed similar binding affinity. IIA2 peptide affinity for
SA23 aptamers, compared to the reported affinity of SA23 for S. aureus of 61.50 ± 22.43 nM, makes IIA2
peptide a good candidate for a device where the displacement of the peptide from SA23 binding site in
the presence of the pathogen bacterium easily allows the S. aureus detection.
The fluorescence behavior of fluorescein upon binding will allow an easy detection of
aptamer:peptide complex displacement by S. aureus. In fact, fluorescein loses fluorescence upon release
from the aptamer, and this can be appreciated by the loss of fluorescence of the nanostructured chip
upon its incubation in the putative contaminated fluid.
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Figure 4. Binding of SA23 to fluorescein-labeled IIA2 peptide recorded by measuring fluorescence
emission changes at 520 nm in 20 µM phosphate buffer at room temperature. Solid line, fitting of
fluorescent data to a binding isotherm (Kd 1.64 ± 0.20 µM); dashed lines, 95% confidence bands.
3.7. Molecular Dynamics Simulation
To further investigate the interaction of SA23 with the most promising peptide IIA2, we modelled
the aptamer-peptide complex, using as guide the coordinates of the CRO protein co-crystallized with a
DNA duplex molecule (PDB ID 6cro [60], see method section for details). To stabilize and investigate
the dynamic and structural properties of the complex, molecular dynamic simulation (MD) in explicit
waters was perfor ed for 500 ns. Although no major perturbations affect the complex, the root
mean square deviation (RMSD) values exhibited by either the complex, the peptide or the aptamer,
with respect to the initial state, reveal the system reaches a global equilibrium in the second half of MD
simulation (Figure S2). In Figure 5 (panel a) a representative structure of the equilibrated part of the
trajectory is shown. Even if changes occurred with respect to the starting modelled structure, a good
protein-aptamer interface is established and preserved along the trajectory and the aptamer maintains
the same loop arrangement dictated by the original folding. We have calculated the occurrence
percentage of hydrogen bonds formed at the complex interface, finding that 3 out of the 7 significative
hydrogen bonds (preserved for more than 30% of the trajectory frames) involve the aptamer backbone
atoms (Figure S3 and Table S1). The remaining connections involve nucleobase atoms of the aptamer.
In detail, Lys39 and Thr6 (out from the peptide length) interact with the phosphate groups of Guanine
5 and 6 (Table 2), Lys32 and His35 make persistent bonds with the nucleobases of guanine 10 (DG10)
and timine 11 (DT11). The last interactions are formed by the exposure of Lys32 and His35 out of
the double strain towards the peptide and are able to anchor the peptide with specific nucleobase
interactions. Likely, the IIA2 peptide sequence is able to maintain the required secondary structure
arrangement to bind the aptamer through non-specific and specific contacts.
The typical electrostatic profile of the protein-aptamer interface, showing positively charged
patches on the peptide side in contact with the negatively charged nucleic acid backbone, is shown in
Figure 5 (panel b and c).
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3.8. Aptamer Immobilization on Ns-ZrO2 
To exploit the possibility to realize an aptamer-based biosensor for bacteria detection the 
microarray technique was applied to test different aptamers and different experimental conditions 
for their immobilization in one single experiment and to test bacteria-aptamer interactions. Figure 6 
shows the image acquired by a scanner/reader of SA23 fluorescent aptamer spotted on a glass slide 
coated with ns-ZrO2 for various concentrations, namely 1, 2, 4 and 8 μM. 
Fig re 5. (a). Global (left) and zoom (right) view of the key interactions at the protein-a tamer interface.
The protein is sh w in blue cartoon and the aptamer in yellow ribbon; the atoms inv lved in each
connection are labeled. (b,c). Frontal and lateral view of molecular dynamic representative structures of
the protein-aptamer complex si ulati ns d rived sing a RMSD based clustering approach. The CRO
protein is shown as surface and colored acco ding to the electrostatic potential. Th red color (negative
potential) arises from an excess of negative charges near the surface and the blu color (positiv
pot ntial) occurs when he surfa e is positively cha ged (±1 kT/e). The whit regions correspond to
fairly neut al potentials. The aptamer is colored yellow.
3.8. Aptamer Immobilization on Ns-ZrO2
To exploit the possibility to realize an aptamer-based biosensor for bacteria detection the microarray
technique was applied to test different aptamers and different experimental conditions for their
immobilization in one single experiment and to test bacteria-aptamer interactions. Figure 6 shows the
image acquired by a scanner/reader of SA23 fluorescent aptamer spotted on a glass slide coated with
ns-ZrO2 for various concentrations, namely 1, 2, 4 and 8 µM.
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the surface [82]. Thus, a new microarray with biotin-TEG aptamers spotted on ns-ZrO2 coated with 
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Figure 6. Scanned image of aptamer-microarray. SA23 spotted on ns-ZrO2 surface covering a glass
slide with different concentrations of 1, 2, 4 and 8 µM.
The isotherms showing the adhesion of SA23 aptamer on different substrates are reported in
Figure 7. The promotion of the adhesion of bare aptamers on ns-ZrO2 substrate with respect to clean
glass is mainly evident at high concentrations. However, the adhesion enhancement is of about a factor
of two for all the concentrations, when the biotinylated aptamers pair with streptavidin deposited on
the nanostructured surface. Furthermore, no manifest hindering to aptamer adhesion appears to be
induced by the TEG spacers.
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Figure 7. Isotherm describing the adsorption behavior of bare aptamers spotted on glass and on ns-ZrO2
and of aptamers functionalized with biotin-TEG 5′ spotted on ns-ZrO2 coated with streptavidin.
3.9. Aptamers Hybridization with Peptides
The SA23 aptamer immobilized on the microa ray was left to hybridize with fluorescein-labeled
IA2 peptide. The total absence o fluorescein signal su gests that aptamers l ose their functionality,
po sibly because of interactions wi the micro rray surface leading to incorrect aptamer folding,
i.e., electrosta ic interactions b twe n the negatively charged DNA sphodiester ackbone and
the positively charged surface. To overcome this problem, biotin-TEG modified aptamers were used
since the 15 atoms spacer should be able to avoid any po sible interaction betw en the aptamers and
the surface [82]. Thus, a new microa ray with biotin-TEG aptamers spo ted on ns-ZrO2 coated with
streptavidin was left to hybridize with the fluorescein-labe led peptide ( IA2). The a says result is
reported in Figure 8 and Figure S4. The expected signal originating from the hybridization betw en
SA23 and IA2 was clearly a preciable, demonstrating that the SA23 aptamer was immobilized with
the co rect folding.
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3.10. Interaction of S. aureus with SA23 Aptamer 
Figure 9 shows representative confocal images from multiple acquisitions of the interaction of 
S. aureus (left panel a) and E. coli (right panel a) with SA23 aptamers immobilized on ns-ZrO2. The 
larger amount of fluorescent spots for S. aureus in comparison with those for E. coli indicates a high 
degree of hybridization of the former bacteria with the aptamer, supporting the effective selectivity 
of the device. This achievement is a fundamental step for the further device assessment, i.e., the 
peptide displacement (Figure 9, panel b). 
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Figure 8. Confocal icroscopy images in the focal plane and along the z-axis. From top to bottom: spot
of streptavidin physico-absorbed on cluster-assembled zirconia surface, SA23 aptamer functionalized
with biotin-TEG immobilized on the surface via biotin-streptavidin bindings, peptide used as probe for
the SA23 aptamer and merge of the three fluorescence signals.
3.10. Interaction of S. aureus ith S 23 pta er
Figure 9 sho s representative confocal i ages fro ultiple acquisitions of the interaction of
S. aureus (left panel a) and E. coli (right panel a) with SA23 aptamers immobilized on ns-ZrO2. The larger
amount of fluorescent spots for S. aureus in comparison with those for E. coli indicates a high degree
of hybridization of the former bacteria with the aptamer, supporting the effective selectivity of the
device. This achievement is a fundamental step for the further device assessment, i.e., the peptide
displacement (Figure 9, panel b).
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3.11. Aptamer:Fluorescent Peptide Complex Displacement by S. aureus
To finally test the functionality of the proposed device, we investigated the capability of S. aureus
to outcompete IIA2 peptide binding to SA23. The ns-ZrO2 substrate functionalized with SA23 and
hybridized with IIA2 peptide was subjected to bacterial incubation followed by a washing step;
then fluorescence was measured. Successful competition of bacteria with respect to the fluorescently
labelled peptides for binding to SA23 is expected to bring about fluorescence loss upon washing.
We compared the fluorescent peptide displacement by S. aureus and E. coli to evaluate the selectivity
of peptide displacement by SA23-S. aureus interaction. The residual fluorescence signal, averaged
on 16 samples using a plate reader, is related to the remaining amount of bound peptides, that is
inversely related to their displacement by bacteria. The data shown in Figure 9 (panel a) and analyzed
in Figure 10 indicate that the device plated with S. aureus exhibits a significantly lower signal with
respect to that with E. coli. This result supports the effectiveness of the device for selective detection of
S. aureus.
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Figure 10. Fluorescence counts of fluorescein-labeled IIA2 peptide upon incubation and washing with
S. aureus and E. coli. All data were obtained from two independent experiments (n = 15). Error bars
represent the standard deviation (* p < 0.05, unpaired t test).
4. Conclusio s
We demonstrated that the rational design of a peptide able to interact with a nucleotide sequence
(aptamer) selected for the recognition of a specific pathogen is a viable approach for the development
of a biosensor. Moreover, we show that the developed zirconia nanostructured substrate is a promising
platfor for generating biosensors based on the immobilization of receptors for the detection of
pathogenic agents.
Important structural determinants related to the aptamer sequence and responsible for the
specificity of the protein targeting have been revealed. MD simulations performed on the modelled
peptide-aptamer complex validated the interaction and identified key residues fundamental for the
complex stabilization. Even if the original interaction pattern, as predicted by the protein-DNA
recognition code [49], has not been totally preserved, these results are of significant relevance,
considering that no X-ray structure of the peptide-aptamer is available and the complex has been
hardly modelled on the structure of the λ-Cro protein interacting with a double strand DNA. This likely
supports the use of the recognition code for the prediction of key residue-nucleobase contacts in
protein-nucleic acids interaction.
The microarray technique allows the development of biosensors to screen in parallel for more
targets, given the possibility to immobilize multiple receptors on the same substrate, retaining
their structure and functionality. Moreover, the high surface-to-volume ratio that characterizes the
porous materials used as substrates for the microarrays, allows the adsorption of a higher amount of
molecules/receptors/aptamers with respect to a flat surface.
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The cluster-assembled zirconia developed in this work was used as reliable support for bioactive
molecules’ immobilization, particularly aptamers, for biosensing applications. The protocol developed
for their immobilization preserves the functionality of the nucleotides. This immobilization technique
well couples with the use of fluorescently labeled synthesized peptides able to selectively bind
specific aptamers.
We finally created a device where the fluorescent chip, loaded with the labeled peptide,
looses fluorescence upon bacterium displacement and consequent peptide release in the fluid. A
colorimetric switch as a detected signal could also be possible by preparing peptides labeled with
solvatochromic fluorophores [83,84].
This device development platform can, in principle, be applied to any analyte for which selective
aptamers have been identified, and whose rapid and specific point-of-care detection is desired.
Supplementary Materials: The following materials are available online at http://www.mdpi.com/1424-8220/20/
17/4977/s1: Peptide synthesis and labeling, Figure S1: Sketch of PSIM protocol applied to one fluorescent aptamer
spotted on ns-ZrO2 at different concentrations. Upper left: spotting; upper right: incubation in a controlled
atmosphere (65% humidity), immersion in a blocking solution and rinsing; bottom left: drying and bottom right:
scanned image, Figure S2: Time evolution of the RMSD values with respect to the starting model. The RMSD
values have been computed considering the C alpha and C5’ atoms of the protein and aptamer, respectively.
The following color code was used: overall complex (mean: 0.7 nm, SD: 0.12 nm): black line, peptide 2AII
(mean: 0.45 nm, SD: 0.07 nm): red, aptamer (mean: 0.59 nm, SD: 0.14 nm): green, Figure S3: Absolute number of
protein-aptamer interfaces hydrogen bonds during the entire trajectory, Figure S4: Sketch of the biotin-streptavidin
paring strategy. The aptamers are functionalized with biotin-TEG 5′and the ns-ZrO2 is coated with streptavidin.
The 15-atom tetraethylene glycol (TEG) spacer is added for minimizing steric hindrance when conjugating the
biotin with other molecules, Table S1: Persistent hydrogen bonds computed for the last 250 ns of simulation time.
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Abbreviations
The following abbreviations (in order of appearance) are used in this manuscript:
PCR polymerase chain reaction
PNA peptide nucleic acid
MALDI-TOF matrix assisted laser desorption ionization time-of-flight
MS mass spectrometry
SELEX systematic evolution of ligands by exponential enrichment
CNT carbon nanotubes
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
PEI-GA glutaraldehyde pre-coated with polyethyleneimine
CFU colony forming unit
PDB protein data bank
MD molecular dynamics
CD circular dirchoism
ns-ZrOx nanostructured zirconia
PMCS pulsed microplasma cluster source
Sensors 2020, 20, 4977 19 of 23
The following abbreviations (in order of appearance) are used in this manuscript:
AFM atomic force microscopy
PSIM protein surface interaction microarray
TEG triethylene glycol
PBS phosphate buffed saline
RT room temperature
RMSD root mean square deviation
References
1. Ferreira, J.S.; Costa, W.L.R.; Cerqueira, E.S.; Carvalho, J.S.; Oliveira, L.C.; Almeida, R.C.C.
Food handler-associated methicillin-resistant Staphylococcus aureus in public hospitals in Salvador, Brazil.
Food Control 2014, 37, 395–400. [CrossRef]
2. Török, E.; Day, N. Staphylococcal and streptococcal infections. Medicine (Baltimore) 2014, 33, 97–100.
[CrossRef]
3. Soriano, J.M.; Font, G.; Moltó, J.C.; Mañes, J. Enterotoxigenic staphylococci and their toxins in restaurant
foods. Trends Food Sci. Technol. 2002, 13, 60–67. [CrossRef]
4. David, M.Z.; Daum, R.S. Community-associated methicillin-resistant Staphylococcus aureus: Epidemiology
and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 2010, 23, 616–687. [CrossRef]
[PubMed]
5. Bannerman, T.L. Staphylococcus, Micrococcus, and other catalase-positive cocci that grow aerobically. In Manual
of Clinical Microbiology, 8th ed.; Murray, P.R., Baron, E.J., Jorgensen, J.H., Pfaller, M.A., Yolken, R.H., Eds.;
American Society for Microbiology: Washington, DC, USA, 2003; Volume 1, pp. 384–404.
6. Evangelista, A.T.; Truant, A.L.; Bourbeau, P.P. Rapid Systems and Instruments for the Identification of
Bacteria. In Manual of Commercial Methods in Clinical Microbiology; Press, A., Ed.; American Society of
Microbiology: Washington, DC, USA, 2002; pp. 22–49. [CrossRef]
7. Evangelista, A.T.; Truant, A.L. Rapid Systems and Instruments for Antimicrobial Susceptibility Testing
of Bacteria. In Manual of Commercial Methods in Clinical Microbiology; Press, A., Ed.; American Society of
Microbiology: Washington, DC, USA, 2002; pp. 413–428. [CrossRef]
8. Weist, K.; Cimbal, A.K.; Lecke, C.; Kampf, G.; Ruden, H.; Vonberg, R.P. Evaluation of six agglutination tests
for Staphylococcus aureus identification depending upon local prevalence of meticillin-resistant S. aureus
(MRSA). J. Med. Microbiol. 2006, 55, 283–290. [CrossRef]
9. Chatzigeorgiou, K.S.; Sergentanis, T.N.; Tsiodras, S.; Hamodrakas, S.J.; Bagos, P.G. Phoenix 100 versus
Vitek 2 in the identification of gram-positive and gram-negative bacteria: A comprehensive meta-analysis.
J. Clin. Microbiol. 2011, 49, 3284–3291. [CrossRef]
10. Zelada-Guillen, G.A.; Sebastian-Avila, J.L.; Blondeau, P.; Riu, J.; Rius, F.X. Label-free detection of Staphylococcus
aureus in skin using real-time potentiometric biosensors based on carbon nanotubes and aptamers.
Biosens. Bioelectron. 2012, 31, 226–232. [CrossRef]
11. Watanabe, K.; Kuwata, N.; Sakamoto, H.; Amano, Y.; Satomura, T.; Suye, S. A smart DNA sensing system for
detecting methicillin-resistant Staphylococcus aureus using modified nanoparticle probes. Biosens. Bioelectron.
2015, 67, 419–423. [CrossRef]
12. Wang, H.Y.; Kim, S.; Kim, J.; Park, S.D.; Uh, Y.; Lee, H. Multiplex real-time PCR assay for rapid detection of
methicillin-resistant staphylococci directly from positive blood cultures. J. Clin. Microbiol. 2014, 52, 1911–1920.
[CrossRef]
13. Peterson, L.R. Molecular laboratory tests for the diagnosis of respiratory tract infection due to
Staphylococcus aureus. Clin. Infect. Dis. 2011, 52, S361–S366. [CrossRef]
14. Frye, A.M.; Baker, C.A.; Rustvold, D.L.; Heath, K.A.; Hunt, J.; Leggett, J.E.; Oethinger, M. Clinical impact of a
real-time PCR assay for rapid identification of staphylococcal bacteremia. J. Clin. Microbiol. 2012, 50, 127–133.
[CrossRef] [PubMed]
15. Sauer, S.; Kliem, M. Mass spectrometry tools for the classification and identification of bacteria.
Nat. Rev. Microbiol. 2010, 8, 74–82. [CrossRef] [PubMed]
16. Fleurbaaij, F.; van Leeuwen, H.; Klychnikov, O.; Kuijper, E.; Hensbergen, P. Mass spectrometry in clinical
microbiology and infectious diseases. Chromatographia 2015, 78, 379–389. [CrossRef]
Sensors 2020, 20, 4977 20 of 23
17. Szabados, F.; Woloszyn, J.; Richter, C.; Kaase, M.; Gatermann, S. Identification of molecularly defined
Staphylococcus aureus strains using matrix-assisted laser desorption/ionization time of flight mass spectrometry
and the Biotyper 2.0 database. J. Med. Microbiol. 2010, 59, 787–790. [CrossRef] [PubMed]
18. Ueda, O.; Tanaka, S.; Nagasawa, Z.; Hanaki, H.; Shobuike, T.; Miyamoto, H. Development of a novel
matrix-assisted laser desorption/ionization time-of-flight mass spectrum (MALDI-TOF-MS)-based typing
method to identify meticillin-resistant Staphylococcus aureus clones. J. Hosp. Infect. 2015, 90, 147–155.
[CrossRef]
19. Bernardo, K.; Pakulat, N.; Macht, M.; Krut, O.; Seifert, H.; Fleer, S.; Hunger, F.; Kronke, M. Identification
and discrimination of Staphylococcus aureus strains using matrix-assisted laser desorption/ionization-time of
flight mass spectrometry. Proteomics 2002, 2, 747–753. [CrossRef]
20. Majumdar, T.; Chakraborty, R.; Raychaudhuri, U. Development of PEI-GA modified antibody based sensor
for the detection of S. aureus in food samples. Food Biosci. 2013, 4, 38–45. [CrossRef]
21. Balasubramanian, S.; Sorokulova, I.B.; Vodyanoy, V.J.; Simonian, A.L. Lytic phage as a specific and
selective probe for detection of Staphylococcus aureus—A surface plasmon resonance spectroscopic study.
Biosens. Bioelectron. 2007, 22, 948–955. [CrossRef]
22. Bandara, A.B.; Zuo, Z.; Ramachandran, S.; Ritter, A.; Heflin, J.R.; Inzana, T.J. Detection of methicillin-resistant
staphylococci by biosensor assay consisting of nanoscale films on optical fiber long-period gratings.
Biosens. Bioelectron. 2015, 70, 433–440. [CrossRef]
23. Singh, A.; Poshtiban, S.; Evoy, S. Recent advances in bacteriophage based biosensors for food-borne pathogen
detection. Sensors 2013, 13, 1763–1786. [CrossRef]
24. Abdalhai, M.H.; Maximiano Fernandes, A.; Bashari, M.; Ji, J.; He, Q.; Sun, X. Rapid and sensitive detection of
foodborne pathogenic bacteria (Staphylococcus aureus) using an electrochemical DNA genomic biosensor and
its application in fresh beef. J. Agric. Food Chem. 2014, 62, 12659–12667. [CrossRef] [PubMed]
25. Tombelli, S.; Minunni, M.; Mascini, M. Analytical applications of aptamers. Biosens. Bioelectron. 2005,
20, 2424–2434. [CrossRef]
26. Schoukroun-Barnes, L.; White, R. Rationally designing aptamer sequences with reduced affinity for controlled
sensor performance. Sensors 2015, 15, 7754–7767. [CrossRef] [PubMed]
27. Cao, X.; Li, S.; Chen, L.; Ding, H.; Xu, H.; Huang, Y.; Li, J.; Liu, N.; Cao, W.; Zhu, Y.; et al. Combining use of a
panel of ssDNA aptamers in the detection of Staphylococcus aureus. Nucleic Acids Res. 2009, 37, 4621–4628.
[CrossRef] [PubMed]
28. Moon, J.; Kim, G.; Park, S.; Lim, J.; Mo, C. Comparison of whole-cell SELEX methods for theidentification of
Staphylococcus aureus-specific DNA aptamers. Sensors 2015, 15, 8884–8897. [CrossRef]
29. Huang, Y.; Chen, X.; Duan, N.; Wu, S.; Wang, Z.; Wei, X.; Wang, Y. Selection and characterization of DNA
aptamers against Staphylococcus aureus enterotoxin C1. Food Chem. 2015, 166, 623–629. [CrossRef]
30. Lian, Y.; He, F.; Wang, H.; Tong, F. A new aptamer/graphene interdigitated gold electrode piezoelectric sensor
for rapid and specific detection of Staphylococcus aureus. Biosens. Bioelectron. 2015, 65, 314–319. [CrossRef]
31. Abbaspour, A.; Norouz-Sarvestani, F.; Noori, A.; Soltani, N. Aptamer-conjugated silver nanoparticles for
electrochemical dual-aptamer-based sandwich detection of Staphylococcus aureus. Biosens. Bioelectron. 2015,
68, 149–155. [CrossRef]
32. Ramlal, S.; Mondal, B.; Lavu, P.S.; Bhavanashri, N.; Kingston, J. Capture and detection of Staphylococcus aureus
with dual labeled aptamers to cell surface components. Int. J. Food Microbiol. 2018, 265, 74–83. [CrossRef]
33. Alizadeh, N.; Memar, M.Y.; Moaddab, S.R.; Kafil, H.S. Aptamer-assisted novel technologies for detecting
bacterial pathogens. Biomed. Pharmacother. 2017, 93, 737–745. [CrossRef]
34. Mairal, T.; Ozalp, V.C.; Lozano Sanchez, P.; Mir, M.; Katakis, I.; O’Sullivan, C.K. Aptamers: Molecular tools
for analytical applications. Anal. Bioanal. Chem. 2008, 390, 989–1007. [CrossRef] [PubMed]
35. Duzgun, A.; Maroto, A.; Mairal, T.; O’Sullivan, C.; Rius, F.X. Solid-contact potentiometric aptasensor
based on aptamer functionalized carbon nanotubes for the direct determination of proteins. Analyst 2010,
135, 1037–1041. [CrossRef] [PubMed]
36. Chang, Y.C.; Yang, C.Y.; Sun, R.L.; Cheng, Y.F.; Kao, W.C.; Yang, P.C. Rapid single cell detection of
Staphylococcus aureus by aptamer-conjugated gold nanoparticles. Sci. Rep. 2013, 3, 1863. [CrossRef]
[PubMed]
37. Langer, R.; Tirrell, D.A. Designing materials for biology and medicine. Nature 2004, 428, 487–492. [CrossRef]
Sensors 2020, 20, 4977 21 of 23
38. Lu, Y.; Liu, J. Functional DNA nanotechnology: Emerging applications of DNAzymes and aptamers.
Curr. Opin. Biotechnol. 2006, 17, 580–588. [CrossRef] [PubMed]
39. Mitragotri, S.; Lahann, J. Physical approaches to biomaterial design. Nat. Mater. 2009, 8, 15–23. [CrossRef]
40. Kohn, J. New approaches to biomaterials design. Nat. Mater. 2004, 3, 745–747. [CrossRef]
41. Negahdary, M. Aptamers in nanostructure-based electrochemical biosensors for cardiac biomarkers and
cancer biomarkers: A review. Biosens. Bioelectron. 2020, 152, 112018. [CrossRef]
42. Zang, Y.; Lei, J.; Ju, H. Principles and applications of photoelectrochemical sensing strategies based on
biofunctionalized nanostructures. Biosens. Bioelectron. 2017, 96, 8–16. [CrossRef]
43. Scopelliti, P.E.; Bongiorno, G.; Milani, P. High-throughput tools for the study of protein-nanostructured
surface interaction. Comb. Chem. High Throughput Screen. 2011, 14, 205–216.
44. Scopelliti, P.E.; Borgonovo, A.; Indrieri, M.; Giorgetti, L.; Bongiorno, G.; Carbone, R.; Podesta, A.; Milani, P.
The effect of surface nanometre-scale morphology on protein adsorption. PLoS ONE 2010, 5, e11862.
[CrossRef] [PubMed]
45. Park, Y.; Ryu, B.; Deng, Q.; Pan, B.; Song, Y.; Tian, Y.; Alam, H.B.; Li, Y.; Liang, X.; Kurabayashi, K.
An integrated plasmo-photoelectronic nanostructure biosensor detects an infection biomarker accompanying
cell death in neutrophils. Small 2020, 16, e1905611. [CrossRef] [PubMed]
46. Arroyo-Curras, N.; Scida, K.; Ploense, K.L.; Kippin, T.E.; Plaxco, K.W. High surface area electrodes
generated via electrochemical roughening improve the signaling of electrochemical aptamer-based biosensors.
Anal. Chem. 2017, 89, 12185–12191. [CrossRef]
47. Zuppolini, S.; Quero, G.; Consales, M.; Diodato, L.; Vaiano, P.; Venturelli, A.; Santucci, M.; Spyrakis, F.;
Costi, M.P.; Giordano, M.; et al. Label-free fiber optic optrode for the detection of class C β-lactamases
expressed by drug resistant bacteria. Biomed. Opt. Express 2017, 8, 5191–5205. [CrossRef]
48. Quero, G.; Zuppolini, S.; Consales, M.; Diodato, L.; Vaiano, P.; Venturelli, A.; Santucci, M.; Spyrakis, F.;
Costi, M.P.; Giordano, M.; et al. Long period fiber grating working in reflection mode as valuable biosensing
platform for the detection of drug resistant bacteria. Sens. Actuator B Chem. 2016, 230, 510–520. [CrossRef]
49. Marabotti, A.; Spyrakis, F.; Facchiano, A.; Cozzini, P.; Alberti, S.; Kellogg, G.E.; Mozzarelli, A. Energy-based
prediction of amino acid-nucleotide base recognition. J. Comput. Chem. 2008, 29, 1955–1969. [CrossRef]
50. Cozzini, P.; Fornabaio, M.; Marabotti, A.; Abraham, D.J.; Kellogg, G.E.; Mozzarelli, A. Simple, intuitive
calculations of free energy of binding for protein-ligand complexes. 1. Models without explicit constrained
water. J. Med. Chem. 2002, 45, 2469–2483. [CrossRef]
51. Ahmed, M.H.; Spyrakis, F.; Cozzini, P.; Tripathi, P.K.; Mozzarelli, A.; Scarsdale, J.N.; Safo, M.A.; Kellogg, G.E.
Bound water at protein-protein interfaces: Partners, roles and hydrophobic bubbles as a conserved motif.
PLoS ONE 2011, 6, e24712. [CrossRef]
52. Amadasi, A.; Spyrakis, F.; Cozzini, P.; Abraham, D.J.; Kellogg, G.E.; Mozzarelli, A. Mapping the energetics
of water-protein and water-ligand interactions with the “natural” HINT forcefield: Predictive tools for
characterizing the roles of water in biomolecules. J. Mol. Biol. 2006, 358, 289–309. [CrossRef]
53. Spyrakis, F.; Cozzini, P.; Bertoli, C.; Marabotti, A.; Kellogg, G.E.; Mozzarelli, A. Energetics of the
protein-DNA-water interaction. BMC Struct. Biol. 2007, 7, 4. [CrossRef]
54. Autiero, I.; Ruvo, M.; Improta, R.; Vitagliano, L. The intrinsic flexibility of the aptamer targeting the ribosomal
protein S8 is a key factor for the molecular recognition. Biochim. Biophys. Acta 2018, 1862, 1006–1016.
[CrossRef] [PubMed]
55. Hermann, T.; Patel, D.J. Adaptive recognition by nucleic acid aptamers. Science 2000, 287, 820–825. [CrossRef]
[PubMed]
56. Pellegrino, S.; Annoni, C.; Contini, A.; Clerici, F.; Gelmi, M.L. Expedient chemical synthesis of 75mer DNA
binding domain of MafA: An insight on its binding to insulin enhancer. Amino Acids 2012, 43, 1995–2003.
[CrossRef]
57. Li, Y.; Yan, X.; Feng, X.; Wang, J.; Du, W.; Wang, Y.; Chen, P.; Xiong, L.; Liu, B.-F. Agarose-based microfluidic
device for point-of-care concentration and detection of pathogen. Anal. Chem. 2014, 86, 10653–10659.
[CrossRef] [PubMed]
58. Qi, X.; Gao, H.; Zhang, Y.; Wang, X.; Chen, Y.; Sun, W. Electrochemical DNA biosensor with chitosan-Co3O4
nanorod-graphene composite for the sensitive detection of Staphylococcus aureus nuc gene sequence.
Bioelectrochemistry 2012, 88, 42–47. [CrossRef]
Sensors 2020, 20, 4977 22 of 23
59. Parisien, M.; Major, F. The MC-Fold and MC-Sym pipeline infers RNA structure from sequence data. Nature
2008, 452, 51–55. [CrossRef]
60. Albright, R.A.; Matthews, B.W. Crystal structure of λ-Cro bound to a consensus operator at 3.0 Å resolution.
J. Mol. Biol. 1998, 280, 137–151. [CrossRef]
61. Hess, B.; Kutzner, C.; Van Der Spoel, D.; Lindahl, E. GRGMACS 4: Algorithms for highly efficient,
load-balanced, and scalable molecular simulation. J. Chem. Theory Comput. 2008, 4, 435–447. [CrossRef]
62. Izadi, S.; Anandakrishnan, R.; Onufriev, A.V. Building water models: A different approach. J. Phys. Chem. Lett.
2014, 5, 3863–3871. [CrossRef]
63. Berendsen, H.J.C.; Grigera, J.R.; Straatsma, T.P. The missing term in effective pair potentials. J. Phys. Chem.
1987, 91, 6269–6271. [CrossRef]
64. Piacenti, V.; Langella, E.; Autiero, I.; Nolan, J.C.; Piskareva, O.; Adamo, M.F.A.; Saviano, M.; Moccia, M.
A combined experimental and computational study on peptide nucleic acid (PNA) analogues of tumor
suppressive miRNA-34a. Bioorg. Chem. 2019, 91, 103165. [CrossRef] [PubMed]
65. Abbruzzetti, S.; Grandi, E.; Bruno, S.; Faggiano, S.; Spyrakis, F.; Mozzarelli, A.; Cacciatori, E.; Dominici, P.;
Viappiani, C. Ligand migration in nonsymbiotic hemoglobin AHb1 from Arabidopsis thaliana. J. Phys. Chem. B
2007, 111, 12582–12590. [CrossRef]
66. Chawla, M.; Autiero, I.; Oliva, R.; Cavallo, L. Energetics and dynamics of the non-natural fluorescent
4AP:DAP base pair. PCCP 2018, 20, 3699–3709. [CrossRef] [PubMed]
67. Autiero, I.; Saviano, M.; Langella, E. In silico investigation and targeting of amyloid β oligomers of different
size. Molecular BioSystems 2013, 9, 2118–2124. [CrossRef] [PubMed]
68. Humphrey, W.; Dalke, A.; Schulten, K. VMD: Visual molecular dynamics. J. Mol. Graph. 1996, 14, 33–38.
[CrossRef]
69. DeLano, W.L. PyMOL. DeLano Sci. San Carlos CA 2002, 700, 5.
70. Daura, X.; Gademann, K.; Jaun, B.; Seebach, D.; van Gunsteren, W.F.; Mark, A.E. Peptide folding: When
simulation meets experiment. Angew. Chem. Int. Ed. 1999, 38, 236–240. [CrossRef]
71. Macut, H.; Hu, X.; Tarantino, D.; Gilardoni, E.; Clerici, F.; Regazzoni, L.; Contini, A.; Pellegrino, S.;
Luisa Gelmi, M. Tuning PFKFB3 bisphosphatase activity through allosteric interference. Sci. Rep. 2019,
9, 20333. [CrossRef]
72. Whitmore, L.; Wallace, B.A. Protein secondary structure analyses from circular dichroism spectroscopy:
Methods and reference databases. Biopolymers 2008, 89, 392–400. [CrossRef]
73. Whitmore, L.; Wallace, B.A. DICHROWEB, an online server for protein secondary structure analyses from
circular dichroism spectroscopic data. Nucleic Acids Res. 2004, 32, W668–W673. [CrossRef]
74. Piseri, P.; Tafreshi, H.V.; Milani, P. Manipulation of nanoparticles in supersonic beams for the production of
nanostructured materials. Curr. Opin. Solid State Mater. Sci. 2004, 8, 195–202. [CrossRef]
75. Borghi, F.; Sogne, E.; Lenardi, C.; Podestà, A.; Merlini, M.; Ducati, C.; Milani, P. Cluster-assembled cubic
zirconia films with tunable and stable nanoscale morphology against thermal annealing. J. Appl. Phys. 2016,
120, 055302. [CrossRef]
76. Podestà, A.; Bongiorno, G.; Scopelliti, P.E.; Bovio, S.; Milani, P.; Semprebon, C.; Mistura, G. Cluster-Assembled
nanostructured titanium oxide films with tailored wettability. J. Phys. Chem. C 2009, 113, 18264–18269.
[CrossRef]
77. Giorgetti, L.; Bongiorno, G.; Podestà, A.; Berlanda, G.; Scopelliti, P.E.; Carbone, R.; Milani, P. Adsorption and
stability of streptavidin on cluster-assembled nanostructured TiOx films. Langmuir 2008, 24, 11637–11644.
[CrossRef] [PubMed]
78. Gailite, L.; Scopelliti, P.E.; Sharma, V.K.; Indrieri, M.; Podestà, A.; Tedeschi, G.; Milani, P. Nanoscale roughness
affects the activity of enzymes adsorbed on cluster-assembled titania films. Langmuir 2014, 30, 5973–5981.
[CrossRef]
79. Mazumder, A.; Maiti, A.; Roy, K.; Roy, S. A Synthetic Peptide mimic of λ-Cro shows sequence-specific
binding in vitro and in vivo. ACS Chem. Biol. 2012, 7, 1084–1094. [CrossRef]
80. Ohlendorf, D.H.; Tronrud, D.E.; Matthews, B.W. Refined structure of Cro repressor protein from bacteriophage
λ suggests both flexibility and plasticity11Edited by P. E. Wright. J. Mol. Biol. 1998, 280, 129–136. [CrossRef]
81. Pellegrino, S.; Ferri, N.; Colombo, N.; Cremona, E.; Corsini, A.; Fanelli, R.; Gelmi, M.L.; Cabrele, C. Synthetic
peptides containing a conserved sequence motif of the Id protein family modulate vascular smooth muscle
cell phenotype. Bioorg. Med. Chem. Lett. 2009, 19, 6298–6302. [CrossRef]
Sensors 2020, 20, 4977 23 of 23
82. Cho, E.J.; Collett, J.R.; Szafranska, A.E.; Ellington, A.D. Optimization of aptamer microarray technology for
multiple protein targets. Anal. Chim. Acta 2006, 564, 82–90. [CrossRef]
83. Dell’Acqua, M.; Ronda, L.; Piano, R.; Pellegrino, S.; Clerici, F.; Rossi, E.; Mozzarelli, A. Based polarity-sensitive
dyes. J. Org. Chem. 2015, 80, 10939–10954.
84. Pirovano, V.; Marchetti, M.; Carbonaro, J.; Brambilla, E.; Rossi, E.; Ronda, L.; Abbiati, G. Synthesis and
photophysical properties of isocoumarin-based D-pi-A systems. Dyes Pigment. 2020, 173, 107917. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
